Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Petros Grivas, Ali Raza Khaki, Trisha M. Wise‐Draper, et al.
Annals of Oncology (2021) Vol. 32, Iss. 6, pp. 787-800
Open Access | Times Cited: 294

Showing 1-25 of 294 citing articles:

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Erin Bange, Nicholas Han, Paul Wileyto, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1280-1289
Open Access | Times Cited: 444
Seroconversion rates following COVID-19 vaccination among patients with cancer
Astha Thakkar, Jesus D. Gonzalez‐Lugo, Niyati Goradia, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1081-1090.e2
Open Access | Times Cited: 341
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
Alfredo Addeo, Pankil Shah, Natacha Bordry, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1091-1098.e2
Open Access | Times Cited: 227
Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer
Mariana Chávez‐MacGregor, Xiudong Lei, Hui Zhao, et al.
JAMA Oncology (2021) Vol. 8, Iss. 1, pp. 69-69
Open Access | Times Cited: 193
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Annika Fendler, Scott T.C. Shepherd, Lewis Au, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1305-1320
Open Access | Times Cited: 158
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
Nicoletta Luxi, Alexia Giovanazzi, Annalisa Capuano, et al.
Drug Safety (2021) Vol. 44, Iss. 12, pp. 1247-1269
Open Access | Times Cited: 124
Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)
Noha Sharafeldin, Benjamin Bates, Qianqian Song, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 20, pp. 2232-2246
Open Access | Times Cited: 119
COVID-19 in patients with hematologic malignancy
Petra Langerbeins, Michael Hallek
Blood (2022) Vol. 140, Iss. 3, pp. 236-252
Open Access | Times Cited: 108
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
Jason D. Goldman, Philip C. Robinson, Thomas S. Uldrick, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 6, pp. e002630-e002630
Open Access | Times Cited: 105
Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative
Qianqian Song, Benjamin Bates, Yu Raymond Shao, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 13, pp. 1414-1427
Open Access | Times Cited: 94
Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies
Daniel Ré, Barbara Seitz-Polski, Vesna Brglez, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 89
Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer
Emma G Khoury, Sarah J Nevitt, William Rohde Madsen, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2210880-e2210880
Open Access | Times Cited: 74
Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021
Weiqiu Jin, Kaichen Huang, Zeyu Ding, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
COVID-19 vaccination and breakthrough infections in patients with cancer
Andrew Schmidt, Chris Labaki, Chih–Yuan Hsu, et al.
Annals of Oncology (2021) Vol. 33, Iss. 3, pp. 340-346
Open Access | Times Cited: 94
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
Annika Fendler, Lewis Au, Scott T.C. Shepherd, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1321-1337
Open Access | Times Cited: 82
Attitudes of Patients with Cancer towards Vaccinations—Results of Online Survey with Special Focus on the Vaccination against COVID-19
Anna Brodziak, Dawid Sigorski, Małgorzata Osmola, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 411-411
Open Access | Times Cited: 76
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
Mario Mairhofer, Lea Kausche, Sabine Kaltenbrunner, et al.
Cancer Cell (2021) Vol. 39, Iss. 9, pp. 1171-1172
Open Access | Times Cited: 61
Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer
Julie Fu, Sonya Reid, Benjamin French, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e224304-e224304
Open Access | Times Cited: 57
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
Annika Fendler, Scott T.C. Shepherd, Lewis Au, et al.
Cancer Cell (2021) Vol. 40, Iss. 2, pp. 114-116
Open Access | Times Cited: 54
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19
Csilla Várnai, Claire Palles, Roland Arnold, et al.
JAMA Network Open (2022) Vol. 5, Iss. 2, pp. e220130-e220130
Open Access | Times Cited: 47
Impact of COVID‐19 in hematopoietic stem cell transplant recipients: A systematic review and meta‐analysis
Moazzam Shahzad, Sibgha Gull Chaudhary, Muhammad Usman Zafar, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 2
Closed Access | Times Cited: 39
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine
Kevin J. Kramer, Erin M. Wilfong, Kelsey Voss, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium
Toni K. Choueiri, Chris Labaki, Ziad Bakouny, et al.
The Lancet Regional Health - Americas (2023) Vol. 19, pp. 100445-100445
Open Access | Times Cited: 31
Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations
Mahendra Rai, Shital Bonde, Alka Yadav, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1224-1224
Open Access | Times Cited: 54
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients
Muhammad Umair Mushtaq, Moazzam Shahzad, Sibgha Gull Chaudhary, et al.
Transplantation and Cellular Therapy (2021) Vol. 27, Iss. 9, pp. 796.e1-796.e7
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top